<DOC>
	<DOC>NCT01434485</DOC>
	<brief_summary>The purpose of this study is to confirm the safety profile / factors which impact safety and efficacy of Nexium capsules in daily clinical usage for the patients who have been prescribed Nexium for "gastric ulcer", "duodenal ulcer", "anastomotic ulcer", "reflux oesophagitis", "non-erosive reflux disease", or "Zollinger-Ellison syndrome"</brief_summary>
	<brief_title>Nexium Capsules Clinical Experience Investigation</brief_title>
	<detailed_description>Nexium capsules Clinical Experience Investigation</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Esophagitis, Peptic</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Zollinger-Ellison Syndrome</mesh_term>
	<mesh_term>Gastrinoma</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Patients treated with Nexium for the first time due to gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, nonerosive reflux disease, ZollingerEllison syndrome. None</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, Zollinger-Ellison syndrome, Nexium</keyword>
</DOC>